PQ32

PQ32 is an anti-tumor agent targeting c-MYCPu27 and KRASG-quadruplexes. It hinders the proliferation of tumor cells, arrests the cell cycle at the G2 phase, and induces apoptosis (apoptosis) . PQ32 suppresses the expression of c-MYC and KRAS genes. It can inhibit tumor growth in mice and is applicable for research in cancers such as lymphoma, breast cancer, lung cancer, hepatocellular carcinoma, and colorectal cancer.